LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 871 6712 0.1298 0.5453
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 14752 6712 2.1976 1.2091
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 2962 6712 0.4413 0.8037
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 12528 6712 1.8663 1.1640
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 95 6712 0.0142 0.1681
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
95.66 27.76 12220 6712 1.8204 1.1572
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00033333
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
1.95 27.76 655 225 2.9093 1.8485
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
1.95 27.76 552 225 2.4518 1.6916
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
3.66 27.76 747 283 2.6309 1.6685
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
3.66 27.76 634 283 2.2330 1.5412
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
5.36 27.76 845 320 2.6377 1.6327
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
5.36 27.76 730 320 2.2787 1.5258
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
7.06 27.76 969 360 2.6917 1.6142
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
7.06 27.76 829 360 2.3028 1.5062
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
8.76 27.76 1070 401 2.6674 1.5800
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
K07